{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:49:21Z","timestamp":1782409761268,"version":"3.54.5"},"reference-count":45,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:sec id=\"sec001\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Erythropoietin is perceived as both a neuroprotectant and a biomarker for hypoxic stress.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec002\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To explore correlations between serum erythropoietin (Epo) concentrations, perinatal risk factors, red blood cell transfusions and recombinant human erythropoietin (rHuEpo) with outcomes including retinopathy of prematurity (ROP) and brain injury on magnetic resonance imaging (MRI) in extremely preterm infants.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec003\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This is a post hoc analysis of data from the Preterm Erythropoietin Neuroprotection Trial of preterm infants born between 24 0\/7 and 27 6\/7 weeks gestation and randomized to placebo or rHuEpo treatment (N\u2009=\u2009941). Serum Epo concentrations were collected within 24 hours (baseline) and at 7, 9, and 14 days. MRI was obtained at 36 weeks postmenstrual age (N\u2009=\u2009220).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec004\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Baseline Epo concentrations negatively correlated with gestational age, delayed cord clamping, and Apgar scores, and positively correlated with intraventricular hemorrhage and risk of death. Neither endogenous Epo at baseline nor trajectories from birth to 14 days were associated with ROP. In the placebo group, Epo at 1 week of life (r\u2009=\u20090.26, p\u2009=\u20090.033) and 2-week area under the curve (r\u2009=\u20090.28, p\u2009=\u20090.019) positively correlated with white matter injury. In the treatment group, Epo at 14 days negatively correlated with white matter injury (r\u2009=\u2009\u22120.35, p\u2009=\u20090.004). Grey matter injury negatively correlated with baseline Epo in the placebo group (r\u2009=\u2009\u22120.27, p\u2009=\u20090.01) but positively correlated in the treatment group (r\u2009=\u20090.23, p\u2009=\u20090.047). Transfusions were associated with severe ROP (p\u2009&lt;\u20090.0001) and total brain injury on MRI (p\u2009=\u20090.007). Transfusion volumes in the first week of life were associated with a greater risk of severe ROP in males (p\u2009=\u20090.0006).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec005\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Endogenous Epo concentrations in preterm infants are influenced by perinatal variables and correlate with poor outcomes. The association of Epo with MRI results differed between placebo and rHuEpo treatment groups. Transfusions were associated with increased ROP and brain injury on MRI.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pone.0348061","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:32:33Z","timestamp":1782408753000},"page":"e0348061","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Erythropoietin, transfusions, and outcomes of retinopathy of prematurity and brain injury in extremely preterm infants: A post hoc analysis of the Preterm Erythropoietin Neuroprotection Trial (PENUT)"],"prefix":"10.1371","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5282-6694","authenticated-orcid":true,"given":"Nancy M.","family":"Fahim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Lunos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6089-5972","authenticated-orcid":true,"given":"Raghavendra B.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael K.","family":"Georgieff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Juul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen C.","family":"Ingolfsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"issue":"6","key":"pone.0348061.ref001","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/s41390-018-0054-4","article-title":"Robust increases in erythropoietin production by the hypoxic fetus is a response to protect the brain and other vital organs","volume":"84","author":"KA Teramo","year":"2018","journal-title":"Pediatr Res"},{"issue":"5","key":"pone.0348061.ref002","doi-asserted-by":"crossref","DOI":"10.1136\/archdischild-2015-309127","article-title":"Systemic endogenous erythropoietin and associated disorders in extremely preterm newborns","volume":"101","author":"M Holm","year":"2016","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"issue":"1","key":"pone.0348061.ref003","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cyto.2014.04.009","article-title":"Endogenous erythropoietin varies significantly with inflammation-related proteins in extremely premature newborns","volume":"69","author":"JW Logan","year":"2014","journal-title":"Cytokine"},{"issue":"3","key":"pone.0348061.ref004","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115083","article-title":"Elevated endogenous erythropoietin concentrations are associated with increased risk of brain damage in extremely preterm neonates","volume":"10","author":"SJ Korzeniewski","year":"2015","journal-title":"PLoS One"},{"key":"pone.0348061.ref005","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.jpeds.2016.09.054","article-title":"Circulating Inflammatory-Associated Proteins in the First Month of Life and Cognitive Impairment at Age 10 Years in Children Born Extremely Preterm","volume":"180","author":"KCK Kuban","year":"2017","journal-title":"J Pediatr"},{"key":"pone.0348061.ref006","doi-asserted-by":"crossref","first-page":"103605","DOI":"10.1016\/j.ebiom.2021.103605","article-title":"Early Biomarkers of Hypoxia and Inflammation and Two-Year Neurodevelopmental Outcomes in the Preterm Erythropoietin Neuroprotection (PENUT) Trial","volume":"72","author":"TR Wood","year":"2021","journal-title":"EBioMedicine"},{"issue":"1","key":"pone.0348061.ref007","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1053\/j.semperi.2008.10.006","article-title":"Current controversies in the management of the anemia of prematurity","volume":"33","author":"N Bishara","year":"2009","journal-title":"Semin Perinatol"},{"key":"pone.0348061.ref008","doi-asserted-by":"crossref","first-page":"388","DOI":"10.2174\/1573396319666221121140627","article-title":"Neonatal Anemia","volume":"19","author":"SE Juul","year":"2023","journal-title":"Curr Pediatr Rev"},{"issue":"1","key":"pone.0348061.ref009","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/s41390-020-01273-w","article-title":"Transfusions and neurodevelopmental outcomes in extremely low gestation neonates enrolled in the PENUT Trial: a randomized clinical trial","volume":"90","author":"PT Vu","year":"2021","journal-title":"Pediatr Res"},{"issue":"1","key":"pone.0348061.ref010","first-page":"40","article-title":"Red blood cell transfusions in preterm newborns and neurodevelopmental outcomes at 2 and 5 years of age","volume":"20","author":"C Fontana","year":"2022","journal-title":"Blood Transfus"},{"key":"pone.0348061.ref011","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.pedneo.2016.03.009","article-title":"Red Blood Cell Transfusion and Clinical Outcomes in Extremely Low Birth Weight Preterm Infants","volume":"58","author":"YC Wang","year":"2017","journal-title":"Pediatr Neonatol"},{"issue":"3","key":"pone.0348061.ref012","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.jpeds.2006.05.011","article-title":"The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants","volume":"149","author":"H Kirpalani","year":"2006","journal-title":"J Pediatr"},{"issue":"6","key":"pone.0348061.ref013","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252655","article-title":"Endogenous erythropoietin concentrations and association with retinopathy of prematurity and brain injury in preterm infants","volume":"16","author":"NM Fahim","year":"2021","journal-title":"PLoS One"},{"issue":"3","key":"pone.0348061.ref014","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1907423","article-title":"A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants","volume":"382","author":"SE Juul","year":"2020","journal-title":"N Engl J Med"},{"issue":"4","key":"pone.0348061.ref015","first-page":"1468","article-title":"Screening Examination of Premature Infants for Retinopathy of Prematurity","volume":"117","author":"Section on Ophthalmology, American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus","year":"2006","journal-title":"Pediatrics"},{"key":"pone.0348061.ref016","first-page":"233","article-title":"Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial","volume":"102","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2004","journal-title":"Trans Am Ophthalmol Soc"},{"issue":"7","key":"pone.0348061.ref017","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The International Classification of Retinopathy of Prematurity revisited","volume":"123","author":"International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"11","key":"pone.0348061.ref018","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.3174\/ajnr.A3521","article-title":"New MR imaging assessment tool to define brain abnormalities in very preterm infants at term","volume":"34","author":"H Kidokoro","year":"2013","journal-title":"AJNR Am J Neuroradiol"},{"key":"pone.0348061.ref019","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpeds.2021.08.040","article-title":"Association between Term Equivalent Brain Magnetic Resonance Imaging and 2-Year Outcomes in Extremely Preterm Infants: A Report from the Preterm Erythropoietin Neuroprotection Trial Cohort","volume":"239","author":"DE Mayock","year":"2021","journal-title":"J Pediatr"},{"issue":"5","key":"pone.0348061.ref020","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1111\/apa.14187","article-title":"Duration of anaemia during the first week of life is an independent risk factor for retinopathy of prematurity","volume":"107","author":"P Lundgren","year":"2018","journal-title":"Acta Paediatr"},{"issue":"10","key":"pone.0348061.ref021","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1001\/jamapediatrics.2020.2271","article-title":"Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates: Post Hoc Analysis of a Randomized Clinical Trial","volume":"174","author":"SE Juul","year":"2020","journal-title":"JAMA Pediatr"},{"key":"pone.0348061.ref022","doi-asserted-by":"crossref","first-page":"106075","DOI":"10.1016\/j.earlhumdev.2024.106075","article-title":"Safety of different cord clamping strategies in the early postnatal period","volume":"195","author":"A Yaman","year":"2024","journal-title":"Early Hum Dev"},{"key":"pone.0348061.ref023","doi-asserted-by":"crossref","first-page":"890988","DOI":"10.3389\/fped.2022.890988","article-title":"A review on development of placental transfusion in term and preterm infants","volume":"10","author":"J Lu","year":"2022","journal-title":"Front Pediatr"},{"issue":"2","key":"pone.0348061.ref024","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/s41390-018-0186-6","article-title":"Erythropoietin serum levels, versus anaemia as risk factors for severe retinopathy of prematurity","volume":"86","author":"P Lundgren","year":"2019","journal-title":"Pediatr Res"},{"issue":"2","key":"pone.0348061.ref025","article-title":"Early erythropoiesis-stimulating agents in preterm or low birth weight infants","volume":"2","author":"A Ohlsson","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0348061.ref026","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1159\/000511262","article-title":"High-Dose Erythropoietin in Extremely Low Gestational Age Neonates Does Not Alter Risk of Retinopathy of Prematurity","volume":"117","author":"Preterm Epo Neuroprotection (PENUT) Trial Consortium","year":"2020","journal-title":"Neonatology"},{"issue":"2","key":"pone.0348061.ref027","article-title":"Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants","volume":"2","author":"SM Aher","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0348061.ref028","doi-asserted-by":"crossref","first-page":"119815","DOI":"10.1016\/j.neuroimage.2022.119815","article-title":"Early brain morphometrics from neonatal MRI predict motor and cognitive outcomes at 2-years corrected age in very preterm infants","volume":"267","author":"AM Pagnozzi","year":"2023","journal-title":"Neuroimage"},{"key":"pone.0348061.ref029","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.jpeds.2021.06.014","article-title":"Neuroimaging of the Preterm Brain: Review and Recommendations","volume":"237","author":"TE Inder","year":"2021","journal-title":"J Pediatr"},{"issue":"11","key":"pone.0348061.ref030","article-title":"Early developmental intervention programmes provided post hospital discharge to prevent motor and cognitive impairment in preterm infants","volume":"2015","author":"A Spittle","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"pone.0348061.ref031","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.clp.2015.04.004","article-title":"Erythropoietin and neonatal neuroprotection","volume":"42","author":"SE Juul","year":"2015","journal-title":"Clin Perinatol"},{"issue":"8","key":"pone.0348061.ref032","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.3390\/cells9081871","article-title":"Preterm Brain Injury, Antenatal Triggers, and Therapeutics: Timing Is Key","volume":"9","author":"DRMG Ophelders","year":"2020","journal-title":"Cells"},{"issue":"2","key":"pone.0348061.ref033","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3233\/NPM-200444","article-title":"Commentary - Do the negative results of the PENUT trial close the book on erythropoietin for premature infant brain?","volume":"13","author":"JJ Volpe","year":"2020","journal-title":"J Neonatal Perinatal Med"},{"issue":"8","key":"pone.0348061.ref034","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1001\/jama.2014.9645","article-title":"Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age","volume":"312","author":"RH-V Leuchter","year":"2014","journal-title":"JAMA"},{"issue":"1","key":"pone.0348061.ref035","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","article-title":"Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances","volume":"8","author":"JJ Volpe","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"pone.0348061.ref036","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clp.2013.11.001","article-title":"Cerebral white and gray matter injury in newborns: new insights into pathophysiology and management","volume":"41","author":"SA Back","year":"2014","journal-title":"Clin Perinatol"},{"issue":"1","key":"pone.0348061.ref037","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1203\/00006450-199801000-00007","article-title":"Erythropoietin and erythropoietin receptor in the developing human central nervous system","volume":"43","author":"SE Juul","year":"1998","journal-title":"Pediatr Res"},{"key":"pone.0348061.ref038","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpeds.2021.12.051","article-title":"Sex Differences in the Association of Pretransfusion Hemoglobin Levels with Brain Structure and Function in the Preterm Infant","volume":"243","author":"A Benavides","year":"2022","journal-title":"J Pediatr"},{"issue":"5","key":"pone.0348061.ref039","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1001\/archpediatrics.2010.269","article-title":"Long-term outcome of brain structure in premature infants: effects of liberal vs restricted red blood cell transfusions","volume":"165","author":"PC Nopoulos","year":"2011","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"20","key":"pone.0348061.ref040","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1080\/14767058.2019.1683157","article-title":"Long-term outcome of brain structure in female preterm infants: possible associations of liberal versus restrictive red blood cell transfusions","volume":"34","author":"A Benavides","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"pone.0348061.ref041","article-title":"Fetal iron and cytochrome c status after intrauterine hypoxemia and erythropoietin administration","volume":"262","author":"MK Georgieff","year":"1992","journal-title":"Am J Physiol"},{"issue":"15","key":"pone.0348061.ref042","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1080\/14767058.2016.1228055","article-title":"Measurement of interleukin-6 (IL-6) and erythropoietin (EPO) in umbilical cords of preterm infants with intraventricular hemorrhage in two hospitals in Tehran","volume":"30","author":"N Khosravi","year":"2017","journal-title":"J Matern Fetal Neonatal Med"},{"key":"pone.0348061.ref043","doi-asserted-by":"crossref","first-page":"1151787","DOI":"10.3389\/fped.2023.1151787","article-title":"Beyond brain injury biomarkers: chemoattractants and circulating progenitor cells as biomarkers of endogenous rehabilitation effort in preterm neonates with encephalopathy","volume":"11","author":"N Efstathiou","year":"2023","journal-title":"Front Pediatr"},{"issue":"5","key":"pone.0348061.ref044","doi-asserted-by":"crossref","first-page":"673","DOI":"10.3109\/14767058.2010.520048","article-title":"Cord blood erythropoietin and interleukin-6 for prediction of intraventricular hemorrhage in the preterm neonate","volume":"24","author":"V Bhandari","year":"2011","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"pone.0348061.ref045","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00381-018-3872-0","article-title":"Lack of relationship between cord blood erythropoietin and intraventricular hemorrhage in premature neonates: a controversial result","volume":"35","author":"K Najib","year":"2019","journal-title":"Childs Nerv Syst"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348061","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T17:32:40Z","timestamp":1782408760000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0348061"}},"subtitle":[],"editor":[{"given":"Sourabh","family":"Dutta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":45,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6,25]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0348061","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]}}}